Northgate Capital related stories
All articles and analysis
Mohr Davidow Combines Portfolio Companies To Fight CancerOn-Q-ity, which announced a $21 million Series A round today, is a combination of two other Mohr Davidow companies -- CELLective Diagnostics and The DNA Repair Company -- that would have languished and probably died had their investors and scientists not figured out a way to keep their technology alive, said Mohr Davidow's Sue Siegel. Both companies had the misfortune of looking for a Series B round in the summer of 2008 -- a slow season to begin with -- and then getting hit with the global financial collapse that followed. "They found themselves not able to raise a financing, not because of the merits of the technology, but because of the environment and the circumstances that existed," Siegel said. "Many companies didn't get financing, and you'll find a graveyard of companies where either the technology was shelved or it got delayed or they're subsisting on minimal dollars until they see another day."
- Week in deals, Oct. 12, 2009
A summary of North American tech companies and other businesses that raised venture financing in the past week
- Visible Measures Adds DAG To Investor Group
Visible Measures Corp., a Boston-based company that measures the behavior of online video audiences, has raised an undisclosed amount of Series C funding from DAG Ventures. The company previously held a $10 million first close on the round, from Northgate Capital, General Catalyst Partners and Mohr Davidow Ventures.
- Exit watch, week of Sept. 14, 2009
News briefs about Visiogen and other VC-backed companies that were recently acquired
- peHUB Wire: Tuesday, August 25, 2009
Random Ramblings
- peHUB Wire: Tuesday, August 25, 2009
Random Ramblings
- Week in deals, July 20, 2009
Summary of North American tech companies and other businesses that raised venture-related financing in the past week